FOOD RESEARCH INTERNATIONAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=806869, encodeId=1de680686972, content=请问一审返修后，多长时间出结果？一审意见还可以，只要回答问题，不需要补实验，一般这种情况还会返给审稿人二审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Sat Aug 08 00:19:17 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861390, encodeId=304086139008, content=审稿速度:2.0 经验分享：2020.03.09 投稿 2020.04.28 大修 2020.05.09 大修后返修 2020.05.30 小修 2020.06.01 小修后返修 2020.06.03 accepted 这是在这个杂志中的第一篇两年间投了三次均被拒这次的速度确实很意外希望该杂志越来越好吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc565414142, createdName=ms2631524123839591, createdTime=Thu Jun 04 06:48:52 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999314, encodeId=d089999314e3, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：食品活性成分 经验分享：7月1日投稿，with editor 10天，14号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe4f2429999, createdName=123b40f0m01(暂无昵称), createdTime=Wed Jul 14 10:09:04 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923872, encodeId=dcd79238e297, content=2021年1月29投稿，当天变成with editor ，状态持续中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=1467e84bm95暂无昵称, createdTime=Tue Feb 09 11:00:38 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857742, encodeId=181b85e74228, content=审稿速度:4.0 经验分享：审稿速度很慢，with editor 一个多月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Sun Feb 23 10:53:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=)]

2020-08-08 autumndz

请问一审返修后，多长时间出结果？一审意见还可以，只要回答问题，不需要补实验，一般这种情况还会返给审稿人二审吗

149 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=806869, encodeId=1de680686972, content=请问一审返修后，多长时间出结果？一审意见还可以，只要回答问题，不需要补实验，一般这种情况还会返给审稿人二审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Sat Aug 08 00:19:17 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861390, encodeId=304086139008, content=审稿速度:2.0 经验分享：2020.03.09 投稿 2020.04.28 大修 2020.05.09 大修后返修 2020.05.30 小修 2020.06.01 小修后返修 2020.06.03 accepted 这是在这个杂志中的第一篇两年间投了三次均被拒这次的速度确实很意外希望该杂志越来越好吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc565414142, createdName=ms2631524123839591, createdTime=Thu Jun 04 06:48:52 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999314, encodeId=d089999314e3, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：食品活性成分 经验分享：7月1日投稿，with editor 10天，14号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe4f2429999, createdName=123b40f0m01(暂无昵称), createdTime=Wed Jul 14 10:09:04 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923872, encodeId=dcd79238e297, content=2021年1月29投稿，当天变成with editor ，状态持续中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=1467e84bm95暂无昵称, createdTime=Tue Feb 09 11:00:38 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857742, encodeId=181b85e74228, content=审稿速度:4.0 经验分享：审稿速度很慢，with editor 一个多月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Sun Feb 23 10:53:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=)]

2020-06-04 ms2631524123839591

审稿速度:2.0
经验分享：2020.03.09 投稿
2020.04.28 大修
2020.05.09 大修后返修
2020.05.30 小修
2020.06.01 小修后返修
2020.06.03 accepted
这是在这个杂志中的第一篇两年间投了三次均被拒这次的速度确实很意外希望该杂志越来越好吧

0 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=806869, encodeId=1de680686972, content=请问一审返修后，多长时间出结果？一审意见还可以，只要回答问题，不需要补实验，一般这种情况还会返给审稿人二审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Sat Aug 08 00:19:17 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861390, encodeId=304086139008, content=审稿速度:2.0 经验分享：2020.03.09 投稿 2020.04.28 大修 2020.05.09 大修后返修 2020.05.30 小修 2020.06.01 小修后返修 2020.06.03 accepted 这是在这个杂志中的第一篇两年间投了三次均被拒这次的速度确实很意外希望该杂志越来越好吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc565414142, createdName=ms2631524123839591, createdTime=Thu Jun 04 06:48:52 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999314, encodeId=d089999314e3, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：食品活性成分 经验分享：7月1日投稿，with editor 10天，14号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe4f2429999, createdName=123b40f0m01(暂无昵称), createdTime=Wed Jul 14 10:09:04 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923872, encodeId=dcd79238e297, content=2021年1月29投稿，当天变成with editor ，状态持续中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=1467e84bm95暂无昵称, createdTime=Tue Feb 09 11:00:38 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857742, encodeId=181b85e74228, content=审稿速度:4.0 经验分享：审稿速度很慢，with editor 一个多月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Sun Feb 23 10:53:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=)]

2021-12-29 乌云背后的幸福线

讨论中一般可以讨论什么？

36 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=806869, encodeId=1de680686972, content=请问一审返修后，多长时间出结果？一审意见还可以，只要回答问题，不需要补实验，一般这种情况还会返给审稿人二审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Sat Aug 08 00:19:17 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861390, encodeId=304086139008, content=审稿速度:2.0 经验分享：2020.03.09 投稿 2020.04.28 大修 2020.05.09 大修后返修 2020.05.30 小修 2020.06.01 小修后返修 2020.06.03 accepted 这是在这个杂志中的第一篇两年间投了三次均被拒这次的速度确实很意外希望该杂志越来越好吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc565414142, createdName=ms2631524123839591, createdTime=Thu Jun 04 06:48:52 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999314, encodeId=d089999314e3, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：食品活性成分 经验分享：7月1日投稿，with editor 10天，14号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe4f2429999, createdName=123b40f0m01(暂无昵称), createdTime=Wed Jul 14 10:09:04 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923872, encodeId=dcd79238e297, content=2021年1月29投稿，当天变成with editor ，状态持续中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=1467e84bm95暂无昵称, createdTime=Tue Feb 09 11:00:38 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857742, encodeId=181b85e74228, content=审稿速度:4.0 经验分享：审稿速度很慢，with editor 一个多月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Sun Feb 23 10:53:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=)]

2021-12-28 小动量

讨论中我和之前发表文章结果不一致怎么处理？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=806869, encodeId=1de680686972, content=请问一审返修后，多长时间出结果？一审意见还可以，只要回答问题，不需要补实验，一般这种情况还会返给审稿人二审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Sat Aug 08 00:19:17 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861390, encodeId=304086139008, content=审稿速度:2.0 经验分享：2020.03.09 投稿 2020.04.28 大修 2020.05.09 大修后返修 2020.05.30 小修 2020.06.01 小修后返修 2020.06.03 accepted 这是在这个杂志中的第一篇两年间投了三次均被拒这次的速度确实很意外希望该杂志越来越好吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc565414142, createdName=ms2631524123839591, createdTime=Thu Jun 04 06:48:52 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999314, encodeId=d089999314e3, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：食品活性成分 经验分享：7月1日投稿，with editor 10天，14号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe4f2429999, createdName=123b40f0m01(暂无昵称), createdTime=Wed Jul 14 10:09:04 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923872, encodeId=dcd79238e297, content=2021年1月29投稿，当天变成with editor ，状态持续中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=1467e84bm95暂无昵称, createdTime=Tue Feb 09 11:00:38 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857742, encodeId=181b85e74228, content=审稿速度:4.0 经验分享：审稿速度很慢，with editor 一个多月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Sun Feb 23 10:53:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=)]

2021-07-14 123b40f0m01(暂无昵称)

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：食品活性成分
经验分享：7月1日投稿，with editor 10天，14号拒稿

52 0

[GetPortalCommentsPageByObjectIdResponse(id=806869, encodeId=1de680686972, content=请问一审返修后，多长时间出结果？一审意见还可以，只要回答问题，不需要补实验，一般这种情况还会返给审稿人二审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Sat Aug 08 00:19:17 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861390, encodeId=304086139008, content=审稿速度:2.0 经验分享：2020.03.09 投稿 2020.04.28 大修 2020.05.09 大修后返修 2020.05.30 小修 2020.06.01 小修后返修 2020.06.03 accepted 这是在这个杂志中的第一篇两年间投了三次均被拒这次的速度确实很意外希望该杂志越来越好吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc565414142, createdName=ms2631524123839591, createdTime=Thu Jun 04 06:48:52 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999314, encodeId=d089999314e3, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：食品活性成分 经验分享：7月1日投稿，with editor 10天，14号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe4f2429999, createdName=123b40f0m01(暂无昵称), createdTime=Wed Jul 14 10:09:04 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923872, encodeId=dcd79238e297, content=2021年1月29投稿，当天变成with editor ，状态持续中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=1467e84bm95暂无昵称, createdTime=Tue Feb 09 11:00:38 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857742, encodeId=181b85e74228, content=审稿速度:4.0 经验分享：审稿速度很慢，with editor 一个多月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Sun Feb 23 10:53:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=)]

2021-02-09 1467e84bm95暂无昵称

2021年1月29投稿，当天变成with editor ，状态持续中

94 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=806869, encodeId=1de680686972, content=请问一审返修后，多长时间出结果？一审意见还可以，只要回答问题，不需要补实验，一般这种情况还会返给审稿人二审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Sat Aug 08 00:19:17 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861390, encodeId=304086139008, content=审稿速度:2.0 经验分享：2020.03.09 投稿 2020.04.28 大修 2020.05.09 大修后返修 2020.05.30 小修 2020.06.01 小修后返修 2020.06.03 accepted 这是在这个杂志中的第一篇两年间投了三次均被拒这次的速度确实很意外希望该杂志越来越好吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc565414142, createdName=ms2631524123839591, createdTime=Thu Jun 04 06:48:52 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999314, encodeId=d089999314e3, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：食品活性成分 经验分享：7月1日投稿，with editor 10天，14号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe4f2429999, createdName=123b40f0m01(暂无昵称), createdTime=Wed Jul 14 10:09:04 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923872, encodeId=dcd79238e297, content=2021年1月29投稿，当天变成with editor ，状态持续中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=1467e84bm95暂无昵称, createdTime=Tue Feb 09 11:00:38 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857742, encodeId=181b85e74228, content=审稿速度:4.0 经验分享：审稿速度很慢，with editor 一个多月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Sun Feb 23 10:53:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=)]

2020-02-23 ms8714998894105664

审稿速度:4.0
经验分享：审稿速度很慢，with editor 一个多月

114 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=806869, encodeId=1de680686972, content=请问一审返修后，多长时间出结果？一审意见还可以，只要回答问题，不需要补实验，一般这种情况还会返给审稿人二审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Sat Aug 08 00:19:17 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861390, encodeId=304086139008, content=审稿速度:2.0 经验分享：2020.03.09 投稿 2020.04.28 大修 2020.05.09 大修后返修 2020.05.30 小修 2020.06.01 小修后返修 2020.06.03 accepted 这是在这个杂志中的第一篇两年间投了三次均被拒这次的速度确实很意外希望该杂志越来越好吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc565414142, createdName=ms2631524123839591, createdTime=Thu Jun 04 06:48:52 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999314, encodeId=d089999314e3, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：食品活性成分 经验分享：7月1日投稿，with editor 10天，14号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe4f2429999, createdName=123b40f0m01(暂无昵称), createdTime=Wed Jul 14 10:09:04 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923872, encodeId=dcd79238e297, content=2021年1月29投稿，当天变成with editor ，状态持续中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=1467e84bm95暂无昵称, createdTime=Tue Feb 09 11:00:38 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857742, encodeId=181b85e74228, content=审稿速度:4.0 经验分享：审稿速度很慢，with editor 一个多月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Sun Feb 23 10:53:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=)]

2019-09-04 ms8259664520863131

审稿速度:2.0
经验分享：aug 10, 2019：submit
aug 12, 2019：with editor
一直到现在with editor状态，

78 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=806869, encodeId=1de680686972, content=请问一审返修后，多长时间出结果？一审意见还可以，只要回答问题，不需要补实验，一般这种情况还会返给审稿人二审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Sat Aug 08 00:19:17 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861390, encodeId=304086139008, content=审稿速度:2.0 经验分享：2020.03.09 投稿 2020.04.28 大修 2020.05.09 大修后返修 2020.05.30 小修 2020.06.01 小修后返修 2020.06.03 accepted 这是在这个杂志中的第一篇两年间投了三次均被拒这次的速度确实很意外希望该杂志越来越好吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc565414142, createdName=ms2631524123839591, createdTime=Thu Jun 04 06:48:52 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999314, encodeId=d089999314e3, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：食品活性成分 经验分享：7月1日投稿，with editor 10天，14号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe4f2429999, createdName=123b40f0m01(暂无昵称), createdTime=Wed Jul 14 10:09:04 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923872, encodeId=dcd79238e297, content=2021年1月29投稿，当天变成with editor ，状态持续中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=1467e84bm95暂无昵称, createdTime=Tue Feb 09 11:00:38 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857742, encodeId=181b85e74228, content=审稿速度:4.0 经验分享：审稿速度很慢，with editor 一个多月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Sun Feb 23 10:53:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=)]

2019-12-19 ms8364037627693300

审稿速度:2.0
经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~

120 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=806869, encodeId=1de680686972, content=请问一审返修后，多长时间出结果？一审意见还可以，只要回答问题，不需要补实验，一般这种情况还会返给审稿人二审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Sat Aug 08 00:19:17 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861390, encodeId=304086139008, content=审稿速度:2.0 经验分享：2020.03.09 投稿 2020.04.28 大修 2020.05.09 大修后返修 2020.05.30 小修 2020.06.01 小修后返修 2020.06.03 accepted 这是在这个杂志中的第一篇两年间投了三次均被拒这次的速度确实很意外希望该杂志越来越好吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc565414142, createdName=ms2631524123839591, createdTime=Thu Jun 04 06:48:52 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999314, encodeId=d089999314e3, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：食品活性成分 经验分享：7月1日投稿，with editor 10天，14号拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe4f2429999, createdName=123b40f0m01(暂无昵称), createdTime=Wed Jul 14 10:09:04 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923872, encodeId=dcd79238e297, content=2021年1月29投稿，当天变成with editor ，状态持续中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=1467e84bm95暂无昵称, createdTime=Tue Feb 09 11:00:38 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857742, encodeId=181b85e74228, content=审稿速度:4.0 经验分享：审稿速度很慢，with editor 一个多月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e005414046, createdName=ms8714998894105664, createdTime=Sun Feb 23 10:53:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=)]

2020-04-13 zhedong

审稿速度:1.0 | 投稿命中率:25.0
经验分享：3.20With editor 4.11 Completed

120 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务